tiprankstipranks
Trending News
More News >

MaxCyte Announces Change in Major Shareholder Holdings

Story Highlights
MaxCyte Announces Change in Major Shareholder Holdings

Confident Investing Starts Here:

The latest update is out from MaxCyte ( (MXCT) ).

MaxCyte, Inc. has announced a change in its major holdings, with BlackRock, Inc. increasing its voting rights in the company to 7.73%. This adjustment in BlackRock’s stake, which was previously 7.70%, reflects a minor yet significant shift in shareholder composition, potentially impacting MaxCyte’s strategic decisions and market perception.

More about MaxCyte

MaxCyte, Inc. operates in the biotechnology industry, focusing on providing cell-engineering platforms that enable the development of advanced therapeutics. The company is known for its proprietary technology used in the creation of cell-based medicines, targeting a range of diseases.

YTD Price Performance: -40.43%

Average Trading Volume: 34,071

Technical Sentiment Signal: Buy

Current Market Cap: £204.2M

See more data about MXCT stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App